World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
47614
World Ranking
500
National Ranking
302

Michael S. Seaman publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael S. Seaman sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 407 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael S. Seaman D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael S. Seaman sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 110 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael S. Seaman is affiliated with the Beth Israel Deaconess Medical Center in the United States. Their research primarily lies at the intersection of medicine and immunology and microbiology, with a significant focus on infectious diseases, virology, and immunology. Within these areas, the scientist has contributed notably to molecular biology and the application of imaging techniques such as radiology and nuclear medicine.

The scientist's work extensively covers topics related to HIV research and treatment, monoclonal and polyclonal antibodies research, and drug development for HIV/AIDS. In addition, a substantial portion of their research addresses SARS-CoV-2 and COVID-19, focusing on clinical research studies, immune cell function and interaction, and vaccines and immunoinformatics approaches.

Recent published papers include:

  • Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host, 2020, New England Journal of Medicine
  • Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic, 2020, JAMA Network Open
  • Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19, 2021, JAMA
  • Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant, 2021, Science
  • Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants, 2021, Science

The scientist frequently publishes in several venues known for high-impact biomedical research. These include bioRxiv (Cold Spring Harbor Laboratory) with 34 publications, Cell with 9 publications, Nature Communications with 7, Journal of Virology with 6, and Cell Reports with 5 publications.

Collaborations have been a key aspect of their research approach. Frequent coauthors include Christy L. Lavine, David C. Montefiori, Michel C. Nussenzweig, Pamela J. Björkman, and Bing Chen, each contributing to multiple joint publications. These collaborations reflect an interdisciplinary engagement across immunology, virology, and molecular biology domains.

Best Publications

  • An immunogenic personal neoantigen vaccine for patients with melanoma

    Patrick A. Ott;Zhuting Hu;Derin B. Keskin;Derin B. Keskin;Sachet A. Shukla;Sachet A. Shukla

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

    Johannes F. Scheid;Hugo Mouquet;Beatrix Ueberheide;Ron Diskin

  • Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.

    Bina Choi;Manish C. Choudhary;James Regan;Jeffrey A. Sparks

  • Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

    Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman

  • Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

    Marina Caskey;Florian Klein;Julio C. C. Lorenzi;Michael S. Seaman

  • Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

    Dan H. Barouch;James B. Whitney;Brian Moldt;Florian Klein

  • Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.

    Michael S. Seaman;Holly Janes;Natalie Hawkins;Lauren E. Grandpre

  • Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.

    Hugo Mouquet;Louise Scharf;Zelda Euler;Yan Liu

  • Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity

    Stylianos Bournazos;Florian Klein;John Pietzsch;Michael S. Seaman

  • Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

    Florian Klein;Ron Diskin;Ron Diskin;Johannes F. Scheid;Johannes F. Scheid;Christian Gaebler;Christian Gaebler

  • Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

    Marcella Sarzotti-Kelsoe;Robert T. Bailer;Ellen Turk;Chen-li Lin

  • HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

    Florian Klein;Ariel Halper-Stromberg;Joshua A. Horwitz;Henning Gruell;Henning Gruell

  • Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia

    Masashi Shingai;Yoshiaki Nishimura;Florian Klein;Hugo Mouquet

  • HIV-1 neutralizing antibodies induced by native-like envelope trimers

    Rogier W. Sanders;Rogier W. Sanders;Marit J. Van Gils;Ronald Derking;Devin Sok;Devin Sok

  • Immune Control of an SIV Challenge by a T Cell-Based Vaccine in Rhesus Monkeys

    Jinyan Liu;Kara L. O’Brien;Diana M. Lynch;Nathaniel L. Simmons

  • Combination therapy with anti-HIV-1 antibodies maintains viral suppression

    Pilar Mendoza;Henning Gruell;Lilian Nogueira;Joy A. Pai

  • Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals

    Davide Corti;Johannes P. M. Langedijk;Andreas Hinz;Michael S. Seaman

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

    Johannes F. Scheid;Johannes F. Scheid;Joshua A. Horwitz;Yotam Bar-On;Edward F. Kreider

  • Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    Mattia Bonsignori;Kwan Ki Hwang;Xi Chen;Chun Yen Tsao

Frequent Co-Authors

Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Dan H. Barouch
Dan H. Barouch Harvard Medical School
David C. Montefiori
David C. Montefiori Duke University
Pamela J. Bjorkman
Pamela J. Bjorkman California Institute of Technology
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
John R. Mascola
John R. Mascola ModeX Therapeutics
Lindsey R. Baden
Lindsey R. Baden Brigham and Women's Hospital
Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Bing Chen
Bing Chen Harvard University
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse career paths, especially in healthcare and research. Many students interested in combining immunology with patient care consider pursuing nursing degrees. For those starting from a non-nursing background, exploring online rn programs for non nurses in florida can be a strategic step, offering flexible options to transition into nursing professionally.

Students looking to advance quickly might find accelerated nursing programs near me particularly appealing. These programs allow for faster completion, enabling graduates to enter the workforce sooner while gaining essential clinical skills.

For those interested in foundational nursing education, understanding which lpn programs are easiest to get into can help in selecting accessible Licensed Practical Nurse programs that still provide solid healthcare training.

Additionally, advancing to specialized roles like Nurse Practitioner is a popular goal. Identifying what is the easiest np program can guide prospective students towards programs that balance rigorous training with manageable entry requirements.

Best Scientists Citing Michael S. Seaman

Trending Scientists